FPHAX: Fidelity® Select Pharmaceuticals Port

Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

FPHAX Fidelity® Select Pharmaceuticals Port

  • Fund
  • FPHAX
  • Price as of: Oct 16, 2019
  • $21.21 - $0.00 - 0.00%
  • Primary Category
  • Uncategorized

FPHAX - Profile

Vitals

  • YTD Return 10.1%
  • 3 Yr Annualized Return 5.5%
  • 5 Yr Annualized Return 0.7%
  • Net Assets $687 M
  • Holdings in Top 10 68.9%

52 WEEK LOW AND HIGH

$21.21
$18.19
$21.65

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.80%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 55.00%

TRADING FEES

  • Max Redemption Fee 0.75%

Min Investment

STANDARD (TAXABLE)

$0

IRA

$2,500

Fund Classification

PRIMARY CATEGORY

Uncategorized
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 10.1%
  • 3 Yr Annualized Total Return 6.7%
  • 5 Yr Annualized Total Return 5.0%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio 1.48%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name Fidelity® Select Pharmaceuticals Portfolio
  • Fund Family Name Fidelity Investments
  • Inception Date Jun 18, 2001
  • Shares Outstanding N/A
  • Share Class No Load
  • Currency USD
  • Domiciled Country United States
  • Manager Karim Suwwan de Felipe

Fund Description

The Fidelity Select Pharmaceuticals Portfolio (FPHAX) is an actively managed fund that focuses on the health care sector. FPHAX hones in on those firms that research and develop drugs, including traditional pharmaceutical firms and biotech drug makers. The fund can hold domestic or foreign stocks of any size. FPHAX’s managers focus on innovation as well as profits when selecting the fund’s underlying portfolio.

Despite its low costs, FPHAX’s extremely narrow focus places it in the satellite position camp within a broader equity portfolio. The fund is run by several Fidelity offices.

FPHAX - Fund Company Quick Screens

FPHAX - Performance

Return Ranking - Trailing

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
YTD 10.1% -3.8% 16.5% 40.17%
1 Yr 0.7% -27.6% 2.7% 4.27%
3 Yr 5.5%* -15.3% 15.2% 33.94%
5 Yr 0.7%* -10.4% 12.6% 46.08%
10 Yr 7.5%* -2.7% 16.3% 62.79%

* Annualized


Return Ranking - Calendar

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
2018 3.8% -25.3% 21.5% 3.60%
2017 8.9% -10.8% 43.9% 78.90%
2016 -17.2% -31.6% 6.9% 59.43%
2015 -3.8% -20.4% 13.8% 64.08%
2014 11.3% -5.8% 31.5% 70.83%

Total Return Ranking - Trailing

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
YTD 10.1% -3.8% 16.5% 40.17%
1 Yr 0.7% -27.6% 2.7% 5.13%
3 Yr 6.7%* -15.3% 17.3% 44.04%
5 Yr 5.0%* -10.4% 18.1% 42.16%
10 Yr 12.7%* -2.7% 16.7% 39.53%

* Annualized


Total Return Ranking - Calendar

Period FPHAX Return Category Return Low Category Return High Rank in Category (%)
2018 4.4% -25.3% 22.2% 4.50%
2017 10.7% -10.8% 45.8% 85.32%
2016 -16.3% -26.4% 8.7% 69.81%
2015 8.3% -16.6% 15.2% 28.16%
2014 24.6% -5.8% 36.7% 50.00%

NAV & Total Return History

FPHAX - Holdings

Concentration Analysis

FPHAX Category Low Category High FPHAX % Rank
Net Assets 687 M 2.52 M 42.7 B 62.99%
Number of Holdings 61 28 390 81.10%
Net Assets in Top 10 477 M 807 K 17.9 B 49.61%
Weighting of Top 10 68.91% 20.8% 76.5% 1.57%

Top 10 Holdings

  1. AstraZeneca PLC ADR 13.53%

  2. Johnson & Johnson 10.29%

  3. Sanofi SA ADR 8.28%

  4. Bristol-Myers Squibb Company 7.96%

  5. Roche Holding AG Dividend Right Cert. 7.20%

  6. Eli Lilly and Co 5.04%

  7. Novartis AG ADR 4.76%

  8. Merck & Co Inc 4.71%

  9. Zoetis Inc Class A 4.02%

  10. Allergan PLC 3.12%


Asset Allocation

Weighting Return Low Return High FPHAX % Rank
Stocks
99.31% 90.21% 103.54% 33.07%
Preferred Stocks
0.53% 0.00% 2.60% 14.96%
Cash
0.16% 0.00% 9.79% 78.74%
Other
0.00% -27.41% 3.81% 39.37%
Convertible Bonds
0.00% 0.00% 1.54% 18.90%
Bonds
0.00% 0.00% 20.60% 18.90%

Stock Sector Breakdown

Weighting Return Low Return High FPHAX % Rank
Healthcare
99.25% 56.60% 99.76% 6.30%
Utilities
0.00% 0.00% 0.00% 10.24%
Technology
0.00% 0.00% 22.28% 71.65%
Real Estate
0.00% 0.00% 5.81% 18.90%
Industrials
0.00% 0.00% 3.11% 37.80%
Financial Services
0.00% 0.00% 5.48% 22.83%
Energy
0.00% 0.00% 0.31% 14.17%
Communication Services
0.00% 0.00% 2.11% 11.02%
Consumer Defense
0.00% 0.00% 33.15% 24.41%
Consumer Cyclical
0.00% 0.00% 5.27% 22.05%
Basic Materials
0.00% 0.00% 1.68% 41.73%

Stock Geographic Breakdown

Weighting Return Low Return High FPHAX % Rank
US
59.25% 59.25% 99.76% 100.00%
Non US
40.06% 0.00% 40.06% 0.79%

FPHAX - Expenses

Operational Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.80% 0.10% 4.94% 83.76%
Management Fee 0.54% 0.09% 1.30% 5.51%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.01% 0.40% N/A

Sales Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee 0.75% 0.75% 2.00% 73.17%

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FPHAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 55.00% 0.00% 341.00% 80.51%

FPHAX - Distributions

Dividend Yield Analysis

FPHAX Category Low Category High FPHAX % Rank
Dividend Yield 0.00% 0.00% 4.42% 27.56%

Dividend Distribution Analysis

FPHAX Category Low Category High Category Mode
Dividend Distribution Frequency Semi-Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

FPHAX Category Low Category High FPHAX % Rank
Net Income Ratio 1.48% -2.24% 1.48% 0.85%

Capital Gain Distribution Analysis

FPHAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Annually Annually

FPHAX - Managers

Karim Suwwan de Felipe

Manager

Start Date

Tenure

Tenure Rank

Jul 01, 2017

2.25

2.3%

Since joining Fidelity Investments in 2010, Mr. Suwwan de Felipe has worked as a research analyst and portfolio manager.


Tenure Analysis

Category Low

0.34

Category High

22.05

Category Average

9.62

Category Mode

19.43